Isolation and characterization of the promoter of the human 5'-nucleotidase (CD73)-encoding gene

被引:43
作者
Hansen, KR
Resta, R
Webb, CF
Thompson, LF
机构
[1] OKLAHOMA MED RES FDN,IMMUNOBIOL & CANC PROGRAM,OKLAHOMA CITY,OK 73104
[2] UNIV OKLAHOMA,HLTH SCI CTR,DEPT MICROBIOL & IMMUNOL,OKLAHOMA CITY,OK 73104
[3] UNIV OKLAHOMA,HLTH SCI CTR,DEPT MED,OKLAHOMA CITY,OK 73104
关键词
adenosine deaminase; firefly luciferase reporter; leukemia; gene regulation; multidrug resistance; purine salvage pathway;
D O I
10.1016/0378-1119(95)00574-9
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Ecto-5'-nucleotidase (NT, CD73) is a purine salvage-pathway enzyme located on the surface of various cell types, including subsets of human lymphocytes and certain leukemias and lymphomas. In addition to purine salvage, NT has proposed roles in lymphocyte maturation and activation, and its expression has been associated with the resistance of some tumor cell lines to chemotherapeutic agents. To better understand the regulation of NT gene expression in normal lymphocyte development and the elevated expression seen in some drug-resistant tumor cell lines, we isolated NT genomic clones containing the promoter region. The genomic DNA upstream from the NT start codon is high in G+C content, with one cAMP-responsive element and five consensus Sp-1 binding sites, but no TATAA box. RNase protection assays identified a cluster of potential transcription start points (tsp). One tsp, at -63 bp relative to the start codon, was confirmed as authentic by 5'-RACE (rapid amplification of cDNA ends) cloning. Transient transfection experiments utilizing luc as a reporter gene have demonstrated that a 155-bp NT genomic DNA segment inclusive of the tsp functions as a promoter in both NT+ (WI-L2 and MG) and NT- (Jurkat, Hela and Raji) cell lines. The addition of 5'-flanking sequences extending as far as -1.9 kb did not confer cell-type-specific expression to the core promoter, However, nuclear run-on analysis of nascent NT transcripts suggested that differential transcription initiation is at least partially responsible for the regulation of NT expression. Thus, additional information. is necessary, either at the chromatin level, or within elements outside of the promoter region, to direct tissue-specific expression of NT.
引用
收藏
页码:307 / 312
页数:6
相关论文
共 22 条
[1]   THE MULTIDRUG RESISTANCE (MDR1) GENE-PRODUCT FUNCTIONS AS AN ATP CHANNEL [J].
ABRAHAM, EH ;
PRAT, AG ;
GERWECK, L ;
SENEVERATNE, T ;
ARCECI, RJ ;
KRAMER, R ;
GUIDOTTI, G ;
CANTIELLO, HF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (01) :312-316
[2]   ADENOSINE LEVELS IN THE POSTIMPLANTATION MOUSE UTERUS - QUANTITATION BY HPLC-FLUOROMETRIC DETECTION AND SPATIOTEMPORAL REGULATION BY 5'-NUCLEOTIDASE AND ADENOSINE-DEAMINASE [J].
BLACKBURN, MR ;
XIANG, G ;
AIRHART, MJ ;
SKALKO, RG ;
THOMPSON, LF ;
KNUDSEN, TB .
DEVELOPMENTAL DYNAMICS, 1992, 194 (02) :155-168
[3]   ADENOSINE IN VERTEBRATE RETINA - LOCALIZATION, RECEPTOR CHARACTERIZATION, AND FUNCTION [J].
BLAZYNSKI, C ;
PEREZ, MTR .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 1991, 11 (05) :463-484
[4]  
CHECHIK BE, 1981, J IMMUNOL, V126, P1003
[5]   DISTRIBUTION OF 5'-NUCLEOTIDASE IN HUMAN LYMPHOID-TISSUES [J].
EDWARDS, NL ;
GELFAND, EW ;
BURK, L ;
DOSCH, HM ;
FOX, IH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (07) :3474-3476
[6]  
GUTENSOHN W, 1990, CANCER-AM CANCER SOC, V66, P1755, DOI 10.1002/1097-0142(19901015)66:8<1755::AID-CNCR2820660819>3.0.CO
[7]  
2-J
[8]   TRANSCRIPTIONAL REGULATION AND CHROMATIN STRUCTURE OF THE HUMAN CD34 GENE PROMOTER REGION [J].
HE, XY ;
COCKERILL, PN ;
CEN, DZ ;
DAVIS, BR .
BLOOD, 1994, 83 (07) :1822-1830
[9]   REGULATING THE FATE OF MESSENGER-RNA - THE CONTROL OF CELLULAR IRON-METABOLISM [J].
KLAUSNER, RD ;
ROUAULT, TA ;
HARFORD, JB .
CELL, 1993, 72 (01) :19-28
[10]   EXPRESSION OF ECTO-5'-NUCLEOTIDASE (CD73) IN NORMAL MAMMARY-GLAND AND IN BREAST-CARCINOMA [J].
KRUGER, KH ;
THOMPSON, LF ;
KAUFMANN, M ;
MOLLER, P .
BRITISH JOURNAL OF CANCER, 1991, 63 (01) :114-118